Michael Bruno

Cooley advised Vividly, the top trade promotion management platform for consumer packaged goods brands, on its $30 million Series B financing. Centana Growth Partners led the funding round. Stephane Levy, Scott Rudin and Michael Bruno led the Cooley team advising Vividly.

Cooley advised Alentis Therapeutics, a clinical-stage biotechnology company developing treatments for Claudin-1 positive tumors and organ fibrosis, on its $181.4 million oversubscribed Series D financing round. Partners Brandon Fenn and Ryan Sansom led the Cooley team advising Alentis Therapeutics.

Cooley advised Spring Health, the top global mental health solution for employers and health plans, on its $100 million Series E financing with a valuation of $3.3 billion.

Cooley advised Enavate Sciences, a top investment firm, as the lead investor in the $182 million Series C financing round of Sionna Therapeutics, a clinical-stage life sciences company dedicated to developing highly effective, differentiated treatments for cystic fibrosis. Partner Brandon Fenn led the Cooley team advising Enavate Sciences.

Cooley advised Tomorrow Health on its $60 million Series B financing. Tomorrow Health is the developer of a data-driven medical equipment sourcing platform intended to streamline ordering and access to home medical equipment supplies for patients and their families. Partner Sacha Ross led the Cooley team.